BBI-355
Product Specifications
CAS Number
2871056-82-3
Target
Chk
Related Pathways
Cell Cycle/Checkpoint
Bioactivity
BBI-355 is an oral, potent, and selective small molecule CHK1 inhibitor with an IC50 of 0.3 nM. It exhibits significant antitumor activity, both as a monotherapy and in combination with targeted therapies, across various ecDNA+ oncogene-amplified tumor models.
Smiles
O(C1=C(C(OC)=CC=C1)C2=CC(NC=3C=NC(C#N)=CN3)=NN2)[C@@H]4C[C@@H](N)C4
Molecular Formula
C19H19N7O2
Molecular Weight
377.4
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
IMPXVZ96I16D13LRNHISLY1MG 1 mg
Monkeypox Virus Zaire Strain 96-I-16 D13L Recombinant Protein N-His Tag Lyophilized 1MG
Sign In for Pricing
View Details P3120-61L-PE 100 µL
PDCD1 (Programmed Cell Death 1, Programmed Cell Death Protein 1, CD279, HGNC:8760, hPD-1, PD1, PD-1, Protein PD-1, SLEB2) (PE) discontinued
Sign In for Pricing
View Details